SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Robert who wrote (2051)12/20/1999 7:31:00 PM
From: Mark The Trader  Respond to of 2068
 
Someone put a buy rec out a few weeks ago . The sector is still out of favor however at current levels and lower its not a bad buy as long as Oxford does not warn .
My price target would be around $ 10 .
Also there has been more press about lawsuits against HMO'S ,that another reason for the decline.
One other note , last week another Analyst put out a buy rec on the stock but said that 4rth quarter could be lite , the 4rth quarter comment is not helping the stock price either.


Mark



To: Robert who wrote (2051)12/29/1999 12:11:00 PM
From: Edward Boghosian  Respond to of 2068
 
Last October-November, the stock bottomed. The recent decline seems to have halted at about 11 which is above the October-November lows. In my opinion, one would not go wrong by buying at these levels, notwithstanding the $1+ rise so far this morning. But, one never knows these things for sure.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News